DxLab Inc. (DxLab) is a biotech startup, spun out of MIT and Harvard in September 2020, developing and commercializing a next-generation point-of-care (POC) diagnostic solution for rapid, on-site detection of dangerous pathogens. Combining proprietary platform technology with novel target detection and signal processing methods, we are advancing a pipeline of rapid POC tests.
Siam Cement Group (SCG) of Bangkok, Thailand is establishing a new business in home healthcare, and look for MIT-connected startups that wish to partner with them on new technologies or field prototypes in Southeast Asia. Including areas such as: telemonitoring devices; tele-medicine, medical devices, home diagnostics, rapid diagnoses, sterilization of surfaces and air, etc.